-DOCSTART- -X- O
DNA -X- _ O
vaccines -X- _ O
present -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
most -X- _ O
cost-effective -X- _ O
platforms -X- _ O
to -X- _ O
develop -X- _ O
global -X- _ O
vaccines -X- _ O
, -X- _ O
which -X- _ O
have -X- _ O
been -X- _ O
tested -X- _ O
for -X- _ O
nearly -X- _ O
three -X- _ O
decades -X- _ O
in -X- _ O
preclinical -X- _ O
and -X- _ O
clinical -X- _ O
settings -X- _ O
with -X- _ O
some -X- _ O
success -X- _ O
in -X- _ O
the -X- _ O
clinic. -X- _ O
However -X- _ O
, -X- _ O
one -X- _ O
of -X- _ O
the -X- _ O
major -X- _ O
challenges -X- _ O
for -X- _ O
the -X- _ O
development -X- _ O
of -X- _ O
DNA -X- _ O
vaccines -X- _ O
is -X- _ O
their -X- _ O
poor -X- _ O
immunogenicity -X- _ O
in -X- _ O
humans -X- _ B-Patient
, -X- _ O
which -X- _ O
has -X- _ O
led -X- _ O
to -X- _ O
refinements -X- _ O
in -X- _ O
DNA -X- _ O
delivery -X- _ O
, -X- _ O
dosage -X- _ O
in -X- _ O
prime -X- _ O
/ -X- _ O
boost -X- _ O
regimens -X- _ O
and -X- _ O
the -X- _ O
inclusion -X- _ O
of -X- _ O
adjuvants -X- _ O
to -X- _ O
enhance -X- _ O
their -X- _ O
immunogenicity. -X- _ O
In -X- _ O
this -X- _ O
review -X- _ O
, -X- _ O
we -X- _ O
focus -X- _ O
on -X- _ O
adjuvants -X- _ B-Intervention
that -X- _ I-Intervention
can -X- _ I-Intervention
enhance -X- _ I-Intervention
the -X- _ I-Intervention
immunogenicity -X- _ I-Intervention
of -X- _ I-Intervention
DNA -X- _ I-Intervention
encoded -X- _ I-Intervention
antigens -X- _ I-Intervention
and -X- _ O
highlight -X- _ O
the -X- _ O
development -X- _ O
of -X- _ O
a -X- _ O
novel -X- _ O
cytolytic -X- _ O
DNA -X- _ O
platform -X- _ O
encoding -X- _ O
a -X- _ O
truncated -X- _ O
mouse -X- _ O
perforin. -X- _ O
The -X- _ B-Outcome
application -X- _ I-Outcome
of -X- _ I-Outcome
this -X- _ I-Outcome
innovative -X- _ I-Outcome
DNA -X- _ I-Outcome
technology -X- _ I-Outcome
has -X- _ I-Outcome
considerable -X- _ I-Outcome
potential -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
development -X- _ I-Outcome
of -X- _ I-Outcome
effective -X- _ I-Outcome
vaccines -X- _ I-Outcome
. -X- _ O

